Novo Holdings has completed the previously announced acquisition of Catalent in a $16.5bn all-cash transaction. The European ...
Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...
Novo Holdings A/S said Monday that it has completed its $16.5 billion all-cash acquisition of Catalent ( CTLT, Financials ).
Heating and air conditioning equipment maker Lennox International Inc. is replacing contract drug maker Catalent Inc. in the ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Novo Nordisk ( (NVO) ) has provided an announcement.
Lennox International (NYSE:LII) will be added to the S&P 500 Index (SP500), replacing Catalent (CTLT) as the contract drug ...
Investor's Business Daily on MSN17h
Lennox To Join S&P 500 Index, Replacing Catalent
Lennox International, an AI cooling play, will join the S&P 500 before the open on Dec. 23. Bill Holdings will take its place ...
Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.
Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of ...
Prothena stock catapulted Thursday after the company's Roche-partnered Parkinson's treatment showed promise in a midstage ...
Vertex Pharmaceuticals reported that its non-opioid drug reduced back pain significantly. But Vertex stock plunged as a ...